{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T16:02:46Z","timestamp":1696521766711},"reference-count":5,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"3","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO"],"published-print":{"date-parts":[[2015,1,20]]},"DOI":"10.1200\/jco.2013.49.8204","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T02:27:05Z","timestamp":1393900025000},"page":"e11-e12","update-policy":"http:\/\/dx.doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":2,"title":["What Is Your Gut Feeling About Opioid Rotation?"],"prefix":"10.1200","volume":"33","author":[{"given":"Neha","family":"Didwaniya","sequence":"first","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhila","family":"Reddy","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raju S.","family":"Gottumukkala","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Bruera","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0269"},{"key":"B2","unstructured":"Exalgo: Hydromorphone HCl extended-release tablets [package insert] 2010 Mallinckrodt Brand Pharmaceuticals Hazelwood, MO Mallinckrodt Brand Pharmaceuticals"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2012.01.007"},{"key":"B4","unstructured":"MS-Contin: Morphine sulfate controlled-release tablets [package insert] 2009 Purdue Pharma Stamford, CT Purdue Pharma"},{"key":"B5","unstructured":"OxyContin: Oxycodone hydrochloride controlled-release tablets [package insert] 2010 Purdue Plarma Stamford, CT Purdue Plarma"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2013.49.8204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:03:20Z","timestamp":1653523400000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2013.49.8204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,20]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,1,20]]}},"alternative-id":["10.1200\/JCO.2013.49.8204"],"URL":"https:\/\/doi.org\/10.1200\/jco.2013.49.8204","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,20]]},"assertion":[{"value":"2014-03-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}